Evidence map›Paper›PMID 39681408›Full record

ArticleBMB reports2025

Development of a prime editor with improved editing efficiency in Arabidopsis.

Yeong Yeop Jeong, Cheljong Hong, Jun Hee Han, Sangsu Bae, Pil Joon Seo

Abstract read
In one paragraph

Article in BMB reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yeong Yeop JeongPlant Genomics and Breeding Institute, Seoul National University, Seoul 08826; Department of Chemistry, Seoul National University, Seoul 08826; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.
Cheljong HongDepartment of Chemistry, Seoul National University, Seoul 08826, Korea.
Jun Hee HanDepartment of Chemistry, Hanyang University, Seoul 04673, Korea.
Sangsu BaeMedical Research Center of Genomic Medicine Institute, Seoul National University College of Medicine, Seoul 03080; Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.
Pil Joon SeoPlant Genomics and Breeding Institute, Seoul National University, Seoul 08826; Department of Chemistry, Seoul National University, Seoul 08826; Department of Biological Sciences, Sungkyunkwan University, Suwon 16419, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prime editing is widely used in many organisms to introduce site-specific sequence modifications such as base substitutions, insertions, and deletions in genomic DNA without generating double-strand breaks. Despite wide-ranging applications of prime editing, prime editors (PEs) have low editing efficiencies, especially in dicot plants. Therefore, PEs are barely used for genome engineering in dicot plant species. Here, based on previous approaches used to improve prime editing efficiency, we generated different combinations of PE components and prime editing guide RNAs (pegRNAs) and examined their prime editing efficiencies in Arabidopsis thaliana protoplasts as a dicot model system. We found that v4e2, in which PE was fused to viral nucleocapsid (NC) protein, RNase Hdeleted M-MLV RT, and a dominant negative version of human mutL homolog 1 (hMLH1dn), showed the highest prime editing efficiency in Arabidopsis protoplasts when it was co-transfected with dual enhanced pegRNA. Our results suggest that the v4e2 PE system could be used for efficient prime editing in dicot plants. [BMB Reports 2025; 58(2): 70-74].

Indexed as

ArabidopsisGene EditingCRISPR-Cas SystemsProtoplastsRNA, Guide, CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID39681408
PMCPMC11875749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.